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Addftlonal Keyphrase: intermethod comparison
A number of mechanized methods for determining blood glucose have been developed. Some of these, such as the hexokinase method, are very specific, but their relatively high cost usually precludes their routine use.
We have used various colorimetric methods such as glucose oxidase/peroxidase ("GOD-Perid"; Boehringer Mannheim Corp., New York, N. Y. 10017), neocuproine, and o-toluidine. Some of these procedures constitute a hazard because of carcinogenic reagents (1) ; some are susceptible to interference from multiple nonsugar substances and from sugars other than glucose. These considerations prompted us to examine a modification (2) of the glucose oxidase (EC 1.1.3.4)/peroxidase (EC 1.11.1.7) method in which a different color reagent, 4-aminophenazone, is used. This compound is innocuous in normal laboratory use (2). Furthermore, uric acid, ascorbic acid, and other common interfering substances are said (3) not to interfere with the color reaction.
Material and Methods
We used the AutoAnalyzer I (Technicon Instruments Corp., Tarrytown, N. Y. 10591). Results for all samples were checked against the hexokinase method, with use of the Du Pont aca (E. I. du Pont de Nemours & Co., Wilmington, Del. 19898).
Reagents: Reagents used were those included in the glucose oxidase/p-aminophenazone method pack (No. 15715; "GOD-PAP"), kindly supplied by Boehringer Mannheim Corp., with a slight modification: the supplier suggested that linearity could be increased by substituting water for For comparison, we analyzed the same samples with an AutoAnalyzer by the usual glucose oxidase/peroxidase method, with an SMA 12/60 (Technicon) by the neocuproine method, and with the DuPont aca by the hexokinase method. Patients' sera included those with known high uric acid and lipid contents, and mixtures of galactose, ascorbic acid, bilirubin, and cysteine with aqueous glucose at various concentrations were also examined. Calibration curves were plotted daily and the glucose concentrations of the different samples were determined from them.
Results
Figures 2 and 3 compare results by the GOD-PAP method with those by the hexokinase and neocuproine methods. Results for samples containing uric acid, galactose, cysteine, bilirubin, or ascorbic acid, and for glossly lipemic sera are summarized in Tables 1 and 2 . To date, >40 000 analyses have been run in our laboratory by the GOD-PAP method; only two problems have been identified: the small interference from lipemic sera and from high concentrations of ascorbic acid. Day-to-day precision with the AutoAnalyzer I was measured with control sera having glucose values of 860 mg/liter and 1.9 g/liter.
Coefficients of variation were 2.5% and 3.2% (n = 30), respectively. For the SMA 12/60 the CV, determined in the same manner, was 3.8% at the 860 mg/liter concentration and 4.5% at the 1.9 g/liter concentration.
Cost per test, as determined from reagent costs for 800 tests, was 10 per test.
We now use this method routinely on two AutoAnalyzer I's and one SMA 12/60.
